NCT07038486

Brief Summary

Parkinson's can cause a wide range of non-motor symptoms (NMS), including pain and problems with mental health, memory and sleep. These affect the quality of life of people with Parkinson's (PwP) and their care partners (CP). If these issues are not recognised and managed quickly, they can result in escalating problems. Many PwP are unsure of the extent and variety of the NMS and how simple adjustments at home could improve them. We have developed a digital system to help PwP monitor their non-motor symptoms and develop skills to self-manage them. Such a tool needs to be simple to use, safe and effective. We will ask 30 PwP and CPs to use the digital tool for 6 months, and we will monitor how they use the tool. PwP and CPs will be asked if they feel more knowledgeable and confident to manage their own symptoms whilst being better able to discuss a problem with their healthcare professional. A smaller group of participants will discuss their experiences in more detail to help pinpoint aspects that work well and those needing adjustment and development. It is thought that the use of this system will result in improved quality of life and increased knowledge and confidence for managing symptoms while safely reducing the time spent by healthcare professionals on manageable non-motor symptoms.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
8mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Aug 2025Dec 2026

First Submitted

Initial submission to the registry

June 17, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 26, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

August 6, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

1.1 years

First QC Date

June 17, 2025

Last Update Submit

January 5, 2026

Conditions

Keywords

Parkinson diseaseSelf-managementmhealthmobile appstelemedicine

Outcome Measures

Primary Outcomes (1)

  • Feasibility of the intervention

    The primary outcome will be assessed using a composite of variables: recruitment, retention, system uptime, adherence/engagement, technical issues, and a review of the health and well-being outcomes (secondary outcomes). Adherence/engagement will be measured using system use data (trend of use over time). This will be supplemented with semi-structured interviews and a user engagement questionnaire to gain a better understanding of users' experience engaging with the intervention and the recommended behaviours. Technical issues will be identified through system use data (including logs of complaints made by participants during the intervention delivery period) as well as asking participants about any technical issues encountered during the semistructured interviews. Product complaints will be collected through feedback recorded via the platform, collected at study assessment points or manually provided via email throughout the study duration.

    Assessed throughout the 6-month study duration

Secondary Outcomes (12)

  • Presence of non-motor symptoms

    Measured monthly for 6 months

  • Patient (and care partner) activation

    Assessed monthly for 6 months

  • Frequency and severity of non-motor symptoms

    Measured at baseline, 3, and 6 months

  • Long-form self-assessment of functioning and well-being related to Parkinson's disease

    Measured at baseline, 3, and 6 months

  • Short-form self-assessment of functioning and well-being related to Parkinson's disease

    Measured monthly for 6 months

  • +7 more secondary outcomes

Study Arms (1)

NMS Assist

EXPERIMENTAL

NMS Assist provides a system of linking PwP, CPs, and healthcare providers (HCPs) to monitor and empower self-management of non-motor symptoms through the use of a mobile app and web portal.

Device: NMS Assist

Interventions

The system enables people with Parkinson's and their care partners to complete questionnaires about symptoms and burden and share that information with their care team. They can also access self-help resources and materials about managing non-motor symptoms. Healthcare providers have a dashboard that flags any worsening symptoms or discrepancies between PwP and CP reports, enabling their to prioritise care and quickly see the status of their patients. The system also enables PwP or CPs to request healthcare contact.

NMS Assist

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All:
  • Age 18 years or over
  • Have compatible smartphone/data access (access to a digital device is a necessary prerequisite of system use, and the formative usability study had success in recruiting participants with varying levels of experience with smartphones)
  • Be fluent in English
  • Able and willing to provide informed consent
  • Able and willing to comply with intervention requirements
  • For clinically diagnosed people with Parkinson's (PwP) (ICD-10-CM G20):
  • Not resident in a care home or nursing home
  • Ambulant
  • Interested in monitoring and managing their NMS
  • For CPs:
  • \- Be caring for a clinically diagnosed PwP (ICD-10-CM G20) who is participating in the study

You may not qualify if:

  • All:
  • Previous involvement in the development or testing of the digital system
  • In a dependent/unequal relationship with the research or care teams or any PPI representatives
  • PwP:
  • Secondary cause of Parkinsonism
  • Significant cognitive impairment or a diagnosis of Parkinson's disease dementia
  • Significant comorbidity, which, in the opinion of the chief investigator, would preclude safe participation in the study or protocol compliance
  • A life expectancy of \<6 months
  • Living in residential care facilities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Newcastle University

Newcastle upon Tyne, Tyne and Wear, NE4 8EA, United Kingdom

RECRUITING

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Digital Health and Clinical Artificial Intelligence

Study Record Dates

First Submitted

June 17, 2025

First Posted

June 26, 2025

Study Start

August 6, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

January 8, 2026

Record last verified: 2026-01

Locations